Company intelligence / Profile preview
Gylden Pharma
Abingdon, Oxfordshire, United Kingdomgyldenpharma.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Gylden has demonstrated safety and proof-of-concept in first-in-human trials with its synthetic T cell–priming vaccine candidates against dengue and betacoronavirus. The gold nanoparticle platform enables robust CD8+ T cell responses with long-lasting immunity. Multiple programs are advancing toward or in early clinical development targeting high-priority infectious diseases.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Synthetic peptide vaccinesGold nanoparticle-based delivery systemsMicroneedle array patches
- Industry
- Biotech
02
Drug pipeline
12 assets11 more assets in the full pipeline.
03
Partnerships
Strategic partnerships with government health authorities for pandemic preparedness and public health response; business development opportunities with national/regional biopharmas are ongoing. Specific partners not named.
Beyond the preview
Go deeper on Gylden Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gylden Pharma.